Maven Securities LTD Travere Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $1.61 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$12.98 - $25.03 $1.38 Million - $2.65 Million
-105,998 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$14.11 - $26.4 $268,414 - $502,207
19,023 Added 21.87%
105,998 $1.57 Million
Q1 2021

May 17, 2021
BUY
$23.37 - $31.77 $983,152 - $1.34 Million
42,069 Added 93.68%
86,975 $2.15 Million
Q4 2020

Feb 12, 2021
BUY
$19.17 - $27.87 $860,848 - $1.25 Million
44,906 New
44,906 $1.24 Million

Others Institutions Holding TVTX

# of Institutions
184
Shares Held
89.5M
Call Options Held
66.9K
Put Options Held
265K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $506M
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email